Prenatal exposure to endocrine disrupting chemicals and risk of testicular cancer (DISRUPT)
Ended Project Grant Awarded Last action
- Award ID
- R01CA236816
- Recipient
-
Region Hovedstaden UEI C1LQEZ7283D5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,175,058
Award facts
- Assistance listing
- 93.393 Cancer Cause and Prevention Research
- Completion date
- Originally
- Funding
-
- $1,506,345.39 Federal
- $668,713.00 Non-federal
- Place of performance
- Denmark
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$25,764 | $0 | |
| Amendment | $261,807 | $0 | |
| Amendment | $261,807 | $261,807 | |
| Amendment | $406,906 | $0 | |
| Amendment | $406,906 | $406,906 | |
| Original award | $194,683 | $0 |
Quick answers
Who received award R01CA236816?
R01CA236816 was awarded to Region Hovedstaden by National Cancer Institute (National Institutes of Health) on April 15, 2020.
How much is award R01CA236816 worth?
$2,175,058 has been obligated on R01CA236816: $1,506,345 in federal funding and $668,713 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award